A global pharmaceutical/ biotech commercial expert

Commercial Strategy & Marketing
Accelerating Brand Adoption | Commercial Assesment | Customer Engagement Strategy | Go-to-Market Strategy | Product Launch | Sharpening the Marketing Message
  • $250.00 - $300.00 / hr
  • // States
  • Save

Irene is a biopharmaceutical business consultant with demonstrated success in building global commercialization plans to drive product launches and life cycle strategies. An experienced brand strategist, Irene has championed products across therapeutic areas, directly launching three blockbuster brands in multiple sclerosis and consulting on the plans of later market entrants.


Irene began her career at Johnson & Johnson, then joined Biogen for the launch of Avonex, to establish their MS Franchise strategy, and to lead the US team in the launch and relaunch of Tysabri. Wanting to work on an early-stage program, Irene joined Novartis Pharmaceutical in Switzerland for the start of the Gilenya development program, globally launching the first oral treatment for MS. With recognized strengths in early-stage development, launch readiness, and go-to-market plans, Irene continues to provide value and insights on commercial strategy.

Project deliverables:

  • Comprehensive brand plans with detailed tactical plans
  • Business plans and market opportunity assessments that define the value proposition and ideal target product profile
  • Identify best commercial practices by functional area, including launch team detailed project plans
  • Defined patient services model and “HUB” structure required for a successful patient journey


Email Verified Irene Hunt

Go-to-launch commercialization plan

Starting from per hour $300.00

Related Case Studies

Irene Hunt
Preparing Generic Competition for a Specialty Blockbuster Therapeutic

Background One of the top three pharma companies in the US was looking to develop a playbook for appropriately handling... read more

Irene Hunt
Business Case With Forecast Model for Neuro Treatment

A small biopharmaceutical company had successfully completed proof-of-concept studies in the steps to develop therapeutics for the treatment of neurological... read more

Irene Hunt
Pre-Commercial Practices for Pharma

An emerging pharma in Cambridge, MA, while undergoing Phase III clinical studies for their first commercial launch, wished to identify... read more



  •  Coolmeen Consulting, LLC

Business Advisor

  •  Goldman Sachs 10,000 Small Businesses Program

VP Marketing, US Chronic Care Brands

  •  Novartis

Senior Director, Global Marketing

  •  Novartis Pharma AG

Senior Director, US Marketing

  •  Biogen

Sales Analysis / Market Research

  •  Janssen Pharmaceutica

Market Research Manager

  •  Johnson & Johnson


MBA Business

  •  Rutgers University - Newark

BS Accounting & Decision Sciences

  •  Rider University